跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RASILEZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RASILEZ
Authorized
STANDARD
RASILEZ
Noden Pharma DAC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1079fee34ce9a14a
Company
Noden Pharma DAC
Type
Standard
Approval Details
Approval Id
1079fee34ce9a14a
Drug Approval Canada Name
RASILEZ
Product Name
RASILEZ
Status
Cancelled Post Market
Status Date
2023-08-31
Original Market Date
2007-11-29
Din
02302071
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.40
Atc Original
C09XA02 ALISKIREN
Atc Name
c 09 xa 02
Aig Number
0152352002
Company Name
Noden Pharma DAC
Company Address
D'Olier Chambers, 16a D'Olier Street, Dublin, Dublin, Ireland
Company Detail Path
/organization/noden-pharma-dac
Company Information
Pharmaceutical Company Name
Noden Pharma DAC
Country Name
Ireland
Website
http://www.nodenpharma.com
Active Ingredients
ALISKIREN (ALISKIREN FUMARATE)
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1079fee34ce9a14a
Type
Standard
Back to Health Canada Approvals